Company Filing History:
Years Active: 2014-2018
Title: Innovations by Kaori Kaneda
Introduction
Kaori Kaneda is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 2 patents, her work focuses on addressing critical health issues through her inventions.
Latest Patents
One of her latest patents is a PDE4 inhibitor, which includes a compound represented by formula (1a) or a pharmacologically acceptable salt thereof. This compound can be utilized as a phosphodiesterase (PDE) inhibitor, with R to R in the formula each independently representing an alkyl group or similar structure. Another notable patent is a topical antifungal agent designed for tinea, which comprises as an active ingredient a compound featuring the skeleton of 2-(1H-pyrazol-1-yl)phenol, represented by the following formula (I) or (II) or a salt thereof.
Career Highlights
Kaori Kaneda is currently employed at Meiji Seika Pharma Co., Ltd., where she continues to innovate and develop new pharmaceutical solutions. Her work has garnered attention for its potential impact on treating various medical conditions.
Collaborations
She collaborates with esteemed colleagues, including Yuji Tabata and Makoto Ohyama, to further enhance the scope and effectiveness of her research.
Conclusion
Kaori Kaneda's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to improving health outcomes. Her work continues to inspire advancements in medical science.